Royal Bank of Canada (RY)
144.75
-0.61 (-0.42%)
NYSE · Last Trade: Sep 3rd, 2:23 AM EDT
Detailed Quote
Previous Close | 145.36 |
---|---|
Open | 143.81 |
Bid | 142.27 |
Ask | 151.16 |
Day's Range | 143.20 - 144.99 |
52 Week Range | 106.10 - 147.64 |
Volume | 1,014,289 |
Market Cap | 207.09B |
PE Ratio (TTM) | - |
EPS (TTM) | - |
Dividend & Yield | 2.052 (1.42%) |
1 Month Average Volume | 1,130,291 |
Chart
About Royal Bank of Canada (RY)
Royal Bank of Canada is a leading financial services institution that provides a wide range of banking and financial solutions to individuals, businesses, and institutions. The bank offers personal and commercial banking services, wealth management, investment banking, and capital markets services. With a robust network of branch locations and digital platforms, it aims to meet the diverse needs of its clients while focusing on innovation and customer service. Royal Bank of Canada is committed to enhancing the financial well-being of its customers and leveraging its expertise to support economic growth in the communities it serves. Read More
News & Press Releases
Shares of biopharmaceutical company Incyte Corporation (NASDAQ:INCY)
jumped 2.4% in the afternoon session after Barclays initiated coverage on the stock with an Overweight rating, helping the shares reach a new 52-week high. The investment bank noted a "compelling inflection point" for the biotechnology firm, highlighting multiple maturing assets that could drive future revenue growth. Further bolstering investor confidence, RBC Capital raised its price target on Incyte to $72, citing strong demand-driven growth from its products. The stock's climb to a 52-week high of $87.27 reflects significant positive momentum, building on a 22.5% year-to-date return. The move was also supported by broader strength in the biotechnology sector and a positive technical trend, with the stock trading above its key 50-day and 200-day moving averages.
Via StockStory · September 2, 2025
Shares of alcohol company Brown-Forman (NYSE:BF.B)
fell 2.4% in the afternoon session after competitor Constellation Brands warned of macroeconomic headwinds affecting consumer demand.
Via StockStory · September 2, 2025
Shares of beer, wine, and spirits company Constellation Brands (NYSE:STZ)
fell 7.4% in the morning session after the company lowered its financial outlook for fiscal year 2026, citing a challenging macroeconomic environment and weakening consumer demand. The owner of popular brands like Corona and Modelo now projects comparable earnings per share of $11.30 to $11.60, a significant reduction from the prior forecast of $12.60 to $12.90. The company also expects a 4% to 6% decline in organic net sales. Management attributed the revision to a sudden drop in beer sales, noting that purchasing declines among Hispanic consumers—a key demographic—were particularly pronounced. This trend, combined with lower volumes and the impact of tariffs, prompted the more cautious outlook.
Via StockStory · September 2, 2025
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at engineered components and systems stocks, starting with RBC Bearings (NYSE:RBC).
Via StockStory · August 31, 2025
Via Benzinga · August 27, 2025
Following rallies in excess of 2,000%, both of these widely owned industry leaders may be set for epic pullbacks.
Via The Motley Fool · August 27, 2025
Shares of alcohol company Brown-Forman (NYSE:BF.B)
fell 4% in the afternoon session after RBC Capital expressed caution about the company's near-term outlook, citing pressure in the U.S. market and challenges with its distribution network.
Via StockStory · August 26, 2025
Shares of beer, wine, and spirits company Constellation Brands (NYSE:STZ)
fell 3% in the afternoon session after a downgrade from Bank of America Securities, which lowered its rating on the stock to Underperform from Neutral and slashed its price target.
Via StockStory · August 26, 2025
Is Wall Street's biggest Palantir bear right about the stock?
Via The Motley Fool · August 26, 2025
Shares of beer, wine, and spirits company Constellation Brands (NYSE:STZ)
fell 3.3% in the afternoon session after RBC Capital trimmed its price target on the stock to $230 from $233, though it maintained an Outperform rating.
Via StockStory · August 25, 2025
JPMorgan and RBC Capital Markets initiated analyst coverage on Figma, a design software company that recently raised $1.22B in an IPO.
Via Benzinga · August 25, 2025
Argenx announced positive study results and plans to seek FDA approval to expand its label for Vyvgart. ARGX stock jumped as RBC initiated coverage.
Via Investor's Business Daily · August 25, 2025
The stock would need to fall to $45 for this to occur.
Via The Motley Fool · August 23, 2025
It's always encouraging to get what appears to be good news from the FDA.
Via The Motley Fool · August 22, 2025
A number of stocks jumped in the afternoon session after the major indices rebounded, as Fed Chair Jerome Powell delivered dovish remarks at the much-awaited Jackson Hole symposium. Powell suggested that with inflation risks moderating and unemployment remaining low, the Federal Reserve might consider a shift in its monetary policy stance, including potential interest rate cuts. This outlook eased market concerns about prolonged high interest rates and their impact on economic growth. The prospect of lower borrowing costs bolstered investor confidence, particularly in sectors that have lagged, leading to a broad rally across the market.
Via StockStory · August 22, 2025
Shares of video communications platform Zoom (NASDAQ:ZM) jumped 10.8% in the afternoon session after the company reported second-quarter financial results that beat analyst expectations. The company's revenue grew 4.7% year-over-year to $1.22 billion, its fastest pace in 11 quarters, while adjusted earnings per share of $1.53 also surpassed estimates. The company also raised its full-year guidance for both revenue and adjusted EPS. The solid results prompted at least one analyst to become more bullish on the stock's prospects. Following the report, RBC Capital raised its price target on the stock to $100 from $95, maintaining an Outperform rating. The strong earnings and positive analyst sentiment fueled the stock's upward momentum.
Via StockStory · August 22, 2025
Biohaven stock surged early Friday after the FDA canceled an upcoming meeting to discuss the benefits and risks of its drug.
Via Investor's Business Daily · August 22, 2025
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages.
Just because a business is in the green today doesn’t mean it will thrive tomorrow.
Via StockStory · August 22, 2025
Shares of fast-food chain Jack in the Box (NASDAQ:JACK)
fell 4.6% in the afternoon session after multiple Wall Street analysts lowered their price targets on the stock. The negative sentiment from Wall Street follows price target reductions from several financial firms. While maintaining their ratings, analysts adjusted their outlooks. TD Cowen lowered its target from $25 to $21, and RBC Capital cut its target to $22 from $30. Similarly, Truist Securities and Barclays both reduced their price targets to $19. Oppenheimer also made a significant adjustment, lowering its target from $44 to $28. These widespread reductions from multiple analysts suggest a more cautious view on the company's near-term stock performance, even though the underlying 'buy' or 'hold' ratings were unchanged.
Via StockStory · August 21, 2025
Insurance coverage is key for any new drug. But it's looking tenuous for Gilead Sciences' newest HIV prevention drug.
Via Investor's Business Daily · August 21, 2025
Shares of residential solar energy company Sunrun (NASDAQ:RUN) jumped 10.4% in the afternoon session after RBC Capital upgraded the stock to 'Outperform' from 'Sector Perform,' citing greater certainty around federal solar tax credits.
Via StockStory · August 18, 2025
Sunrun is experiencing another surge in positive sentiment from Wall Street. RBC Capital upgraded the residential solar company's stock from Sector Perform to Outperform.
Via Benzinga · August 18, 2025
Shares of ride sharing service Lyft (NASDAQ: LYFT)
jumped 9.5% in the afternoon session after the company announced its co-founders, Logan Green and John Zimmer, will step down from the board next year. The rideshare company announced that co-founders Logan Green and John Zimmer will exit the board in August 2025, completing a two-year transition plan. As part of the change, they will convert their special Class B shares to Class A shares, eliminating the dual-class structure and establishing equal voting rights for all shareholders.
Via StockStory · August 15, 2025